⌘K

Home/Filings/4/A/0001729637-23-000003

4/A//SEC Filing

Robinson James George 4/A

Accession 0001729637-23-000003

CIK 0001018735other

View on SEC.gov Company Profile

Filed

May 17, 8:00 PM ET

Accepted

May 18, 4:09 PM ET

Size

4.8 KB

Accession

0001729637-23-000003

Insider Transaction Report

Form 4/AAmended

Period: 2023-04-25

NYMOX PHARMACEUTICAL CORPNYMX

Robinson James George

Director

Transactions

Purchase
Common Stock
2023-04-25$0.45/sh+40,000$18,000→ 4,742,065 total

Documents

1 file

4
primary_doc.xml
PRIMARY DOCUMENT

Issuer

NYMOX PHARMACEUTICAL CORP

CIK 0001018735

Entity typeother

Related Parties

1

filerCIK 0001651844

Filing Metadata

Form type: 4/A
Filed: May 17, 8:00 PM ET
Accepted: May 18, 4:09 PM ET
Size: 4.8 KB

View on SEC.gov